ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,590.37
-0.77%
US Tech 100
19,847.60
-1.35%
Dow Jones
39,813.78
0.23%
Brent Oil
85.105
0.06%
Bitcoin
57,596.71
-0.28%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Castle Biosciences Inc (CSTL) Quote

Castle Biosciences Inc

Castle Biosciences Inc (CSTL)

NASDAQ
18.16
0.68
( 3.89% )
Updated: 11:18:50
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
18.16
Bid
18.16
Ask
18.28
Volume
100,333
17.6464 Day's Range 18.40
12.07 52 Week Range 25.91
Market Cap
482.574M
Previous Close
17.48
Open
17.98
Last Trade
5
@
18.21
Last Trade Time
11:19:24
Financial Volume
$ 1,809,862
VWAP
18.0386
Average Volume (3m)
288,296
Shares Outstanding
27,607,183
Dividend Yield
-
PE Ratio
-8.76
Earnings Per Share (EPS)
-2.08
Revenue
219.79M
Net Profit
-57.47M

About Castle Biosciences Inc

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanom... Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Website
www.castlebiosciences.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Castle Biosciences Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker CSTL. The last closing price for Castle Biosciences was $17.48. Over the last year, Castle Biosciences shares have traded in a share price range of $ 12.07 to $ 25.91.

Castle Biosciences currently has 27,607,183 shares outstanding. The market capitalization of Castle Biosciences is $482.57 million. Castle Biosciences has a price to earnings ratio (PE ratio) of -8.76.

Castle Biosciences (CSTL) Options Flow Summary

CSTL Options Flow

Overall Flow

Bullish

Net Premium

40k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

CSTL Latest News

More News

Castle Biosciences Honored with Top Workplaces Awards

Castle earns recognition as an Arizona Top Workplace, a national Healthcare Industry Top Workplace and receives five Top Workplaces Culture Excellence Awards Castle Biosciences, Inc. (Nasdaq:...

5 hours ago
Business Wire

Recent AGA Clinical Practice Guideline Acknowledges That Individuals Who May Be at Increased Risk of Progression to Esophageal Cancer Might Be Identified Using Tissue-Based Biomarkers, Particularly Castle Biosciences’ TissueCypher® Test

Castle’s TissueCypher test has been shown to improve the risk stratification of patients with Barrett’s esophagus (BE)1,2 Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health...

June 24 2024
Business Wire

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on June 14, 2024, the Compensation Committee of its...

June 20 2024
Business Wire

Castle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award Winner

Maetzold selected as a winner of Ernst & Young’s prestigious annual awards among 48 visionary finalists in the Gulf South region, encompassing Central and South Texas, Louisiana and...

June 14 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

June 04 2024
Edgar (US Regulatory)

Castle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging Surveillance

Castle to present a second poster on its DecisionDx®-UM test sharing data from an ongoing prospective, multi-center study of patients with uveal melanoma (UM) led by the Collaborative Ocular...

May 30 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

May 29 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

May 29 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.972-5.0804934141819.13219.489916.96561317417.65415424CS
4-5.06-21.791559000923.2223.561316.96536435520.22128063CS
12-0.68-3.609341825918.8425.9116.96528829622.06047685CS
26-3.14-14.741784037621.325.9116.96525949721.80288312CS
52-1.84-9.22025.9112.0727962119.47635868CS
156-53.86-74.78478200572.0278.5859.260128215825.91668043CS
260-1.84-9.220107.699.260125365634.03140365CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LCFYLocafy Ltd
$ 10.1002
(335.33%)
25.15M
KZIAKazia Therapeutics Ltd
$ 1.164
(74.20%)
159.55M
BDRXBiodexa Pharmaceuticals PLC
$ 1.11
(56.10%)
55.68M
VLCNVolcon Inc
$ 5.40
(47.95%)
23.23M
CYNCYNGN Inc
$ 5.40
(36.36%)
9.68M
IVPInspire Veterinary Partners Inc
$ 5.02
(-32.16%)
1.39M
CETUUCetus Capital Acquisition Corporation
$ 7.00
(-29.72%)
1.22k
SLRXSalarius Pharmaceuticals Inc
$ 2.09
(-23.79%)
1.77M
CINGCingulate Inc
$ 0.504
(-22.22%)
999.7k
MCACMonterey Capital Acquisition Corporation
$ 6.82
(-17.33%)
17.39k
KZIAKazia Therapeutics Ltd
$ 1.164
(74.20%)
147.87M
NVDANVIDIA Corporation
$ 130.30
(-3.42%)
136.81M
MAXNMaxeon Solar Technologies Ltd
$ 0.2057
(-2.42%)
96.07M
SOUNSoundHound AI Inc
$ 5.5001
(8.48%)
79.95M
SQQQProShares UltraPro Short QQQ
$ 7.44
(3.77%)
73.23M

Discussion

View Full Feed
oilin07 oilin07 18 seconds ago
Lets do it
BLLB
newman2021 newman2021 22 seconds ago
MMs tried to create panic this morning, imo. The Mfrs have naked shorted with a million and half fake shares, and are trying to cover those shares now, imo. See no brave longs are selling. Like tryn2, wish I have dry powder to keep loading more and more.
NWBO
badgerkid badgerkid 28 seconds ago
A morning of simple math: Let's assume $425 million for annual expenses - it's probably going up a bit with expansion, more trials, European rollout, more employees, etc.

Let's assume all in a treatment with Amtagvi and Proleukin produces revenue for Iovance of $425,000/patient on
IOVA
I am done I am done 28 seconds ago
$MMMW Mass Megawatts introduces a patent-pending solar photovoltaic concentration innovation. - Increasing solarpanel output by over 105%
https://finance.yahoo.com/news/mass-megawatts-announces-solar-product-111400367.html
MMMW
Zorax Zorax 30 seconds ago
Transcripts do not reflect what actually happened during a trial .
Transcripts of a trial can are very often modified to hide whatever criminal activity accured during the trial. What transcripts are you referring to exactly?
JRoon71 JRoon71 30 seconds ago
Ram, I think they are at the mercy of the timeline of the Chinese system. Chromosome seems to understand the process pretty well. But, hopefully they can find a way to gain reimbursement in 2025 as opposed to 2026.

Keep in mind the timeline we have witnessed in many other countries -
AMRN
gfp927z gfp927z 33 seconds ago
MCD - key support (240-245) held, so hopefully recovers from here, though still early.



---
MCD
wakeupdummy wakeupdummy 49 seconds ago
well wadda ya know
who says you can't beat a dead horse? ;-)
GVSI
Dubster watching Dubster watching 1 minute ago
NVDA so overpriced still. Ridiculous to think valuations aren’t a concern.

I hope YOU are adding.
NVDA
Carjockey2 Carjockey2 2 minutes ago
Once again thank you I didn't even mind interrupting my summer vacation last week picking up ..0003's

You're the best
GRLT
Lime Time Lime Time 2 minutes ago
66.66 new 52 week high 🚀
CARR
Investor082 Investor082 2 minutes ago
KOLs do not agree with you regarding efficacy and safety. Soon UK regulator will side with KOLs as well. I’d trust them over you.

Regarding ripping off shareholders, we will see what they come up at UK approval. If they dangle another carrot like Flaskworks and do not come up with bi
NWBO
Diamondhands45 Diamondhands45 3 minutes ago
Bro she was drunk. You are a looney
TSLA
$Money Bags$ $Money Bags$ 3 minutes ago
Quarterly should be out tomorrow.
RJDG
glenn1919 glenn1919 3 minutes ago
PRCH...........TRNR..............MULN..........................https://www.stockscores.com/charts/charts/?ticker=PRCH
https://www.stockscores.com/charts/charts/?ticker=MULN
https://www.stockscores.com/charts/charts/?ticker=TRNR
MULN PRCH TRNR
ducci1 ducci1 3 minutes ago
Checked U SPY Chart----SPY 30 min Red Line around 559--- ( 60 min at 552 ) looks like headin there !!LOL!!
SPY
Imindog Imindog 3 minutes ago
Keep in mind they have to net 600k in q2 just to break even for the year and achieve their 7 figure net income positive goal!! You actually think that will happen ? Hell no is the answer !! More pathetic results from a pathetic company and an absolutely deserved pathetic share price!! Once again as
IQST
OkieThomas OkieThomas 3 minutes ago
I'm calling PETA, or someone. That's just thievery! Nice haul!
AFFU
Chartmaster Chartmaster 3 minutes ago
60 support holding, I expect a 72 close today!
SMCE
power11 power11 3 minutes ago
THIS HYPE AIN'T GONNA WORK , FOLLOW POWER11 TO FREEDOM
LOOOOOOOOOOOOOOOOOOOOOOONG 20,000 TSLQ
TSLA
Saving Grace Saving Grace 4 minutes ago
Bitcoin Drops as German Government Unloads Over $900M Worth of BTC

Wallets linked to the German government still hold some 23,788 bitcoin, meaning that it has already sold more than half of its seized assets, according to Arkham Intelligence data.

The price action came
BTCUSD
Mark Mark 4 minutes ago
$CHRO 1.44
CHRO
gfp927z gfp927z 4 minutes ago
GNRC hopefully creeping back up to test key resistance (~ 155)



---
GNRC
Chartmaster Chartmaster 4 minutes ago
Agreed, successful test of 20 day MA at .00435, almost kissed it at 40, now bouncing hard!
SMCE

Your Recent History

NASDAQ
CSTL
Castle Biosciences
BIT
F18866
Vontobel Financial Produ...
BIT
L82726
Credit Agricole Corporat...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved